Literature DB >> 12384216

Methylene blue restores spatial memory retention impaired by an inhibitor of cytochrome oxidase in rats.

Narriman Lee Callaway1, Penny D Riha, Kathryn M Wrubel, David McCollum, F Gonzalez-Lima.   

Abstract

Cytochrome oxidase is the mitochondrial enzyme that catalyzes the utilization of oxygen for the electron transport chain during cellular respiration. Chronic subcutaneous infusion of sodium azide, an inhibitor of cytochrome oxidase, produced a spatial memory retention deficit in rats in a holeboard maze. Methylene blue, which has been shown to increase oxygen consumption in vitro, was used to restore mitochondrial electron transport in order to facilitate memory consolidation. Administration of 1 mg/kg methylene blue after training, during the memory consolidation period, completely restored the memory retention impaired by the inhibitor of cytochrome oxidase. This suggests that methylene blue may compensate for impaired mitochondrial respiration and improve spatial memory retention. Memory retention deficits found in some neurodegenerative diseases may be improved by drugs targeting impaired mitochondrial respiration. Copyright 2002 Elsevier Science Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12384216     DOI: 10.1016/s0304-3940(02)00827-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  36 in total

1.  Methylene blue reduces aβ levels and rescues early cognitive deficit by increasing proteasome activity.

Authors:  David X Medina; Antonella Caccamo; Salvatore Oddo
Journal:  Brain Pathol       Date:  2011-03       Impact factor: 6.508

Review 2.  Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue.

Authors:  Julio C Rojas; Aleksandra K Bruchey; F Gonzalez-Lima
Journal:  Prog Neurobiol       Date:  2011-11-03       Impact factor: 11.685

3.  Multimodal Randomized Functional MR Imaging of the Effects of Methylene Blue in the Human Brain.

Authors:  Pavel Rodriguez; Wei Zhou; Douglas W Barrett; Wilson Altmeyer; Juan E Gutierrez; Jinqi Li; Jack L Lancaster; Francisco Gonzalez-Lima; Timothy Q Duong
Journal:  Radiology       Date:  2016-06-28       Impact factor: 11.105

4.  Methylene blue does not bypass Complex III antimycin block in mouse brain mitochondria.

Authors:  Artem P Gureev; Ekaterina A Shaforostova; Vasily N Popov; Anatoly A Starkov
Journal:  FEBS Lett       Date:  2019-02-20       Impact factor: 4.124

5.  Neuroprotective and Functional Improvement Effects of Methylene Blue in Global Cerebral Ischemia.

Authors:  Qing Lu; Donovan Tucker; Yan Dong; Ningjun Zhao; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2015-10-03       Impact factor: 5.590

6.  The metabolic enhancer piracetam ameliorates the impairment of mitochondrial function and neurite outgrowth induced by beta-amyloid peptide.

Authors:  C Kurz; I Ungerer; U Lipka; S Kirr; T Schütt; A Eckert; K Leuner; W E Müller
Journal:  Br J Pharmacol       Date:  2010-03-09       Impact factor: 8.739

7.  Selective lamina dysregulation in granular retrosplenial cortex (area 29) after anterior thalamic lesions: an in situ hybridization and trans-neuronal tracing study in rats.

Authors:  E Amin; N Wright; G L Poirier; K L Thomas; J T Erichsen; J P Aggleton
Journal:  Neuroscience       Date:  2010-06-04       Impact factor: 3.590

8.  Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam.

Authors:  Kristina Leuner; Christopher Kurz; Giorgio Guidetti; Jean-Marc Orgogozo; Walter E Müller
Journal:  Front Neurosci       Date:  2010-09-07       Impact factor: 4.677

Review 9.  Cellular and molecular actions of Methylene Blue in the nervous system.

Authors:  Murat Oz; Dietrich E Lorke; Mohammed Hasan; George A Petroianu
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

10.  Methylene blue provides behavioral and metabolic neuroprotection against optic neuropathy.

Authors:  Julio C Rojas; Joseph M John; Jung Lee; F Gonzalez-Lima
Journal:  Neurotox Res       Date:  2009-02-24       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.